Cell therapy weekly: Stem cell therapy improves osteoarthritis quality of life by 290%
This week: Novo Holdings to invest £53.5 million in Oxford Biomedica plc and new collaboration takes aim at manufacturing scalability.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>